| Company/Division name | Siemens |
| Type of work | Manufacturing |
| If manufacturing, is the company an OEM? | Yes |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2017 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 300 |
| Country(ies) from which reshored: | Germany |
| City reshored to: | Walpole |
| State(s) reshored to: | MA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals, Medical Equipment & Supplies |
| Product(s) reshored | Medical Diagnostic Tests |
| What domestic positive factors made reshoring more attractive? | Government Incentives, Manufacturing/engineering joint innovation (R&D), Skilled workforce availability/training |
